<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" VersionID="2" Owner="NLM">
      <PMID Version="2">35401904</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">1930-0433</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>17</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Radiology case reports</Title>
          <ISOAbbreviation>Radiol Case Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A rare case of COVID-19 vaccine-induced myopericarditis in a young adult.</ArticleTitle>
        <Pagination>
          <StartPage>1916</StartPage>
          <EndPage>1920</EndPage>
          <MedlinePgn>1916-1920</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.radcr.2022.03.039</ELocationID>
        <Abstract>
          <AbstractText>Although extremely rare, the COVID-19 mRNA vaccine can induce myopericarditis without left ventricular dysfunction, and there have been rare reports of such incidents. However, these prior cases either did not have pericardial effusion without reduced left ventricular ejection fraction or had a more typical presentation of vaccine-induced myopericarditis such as shortness of breath or tactile temperature. We present a rare case of a 25-year-old man who developed myopericarditis following administration of the second dose of COVID-19 mRNA Vaccine. As vaccination plays a significant role in the fight against the COVID-19 pandemic, it is essential to highlight the physical manifestations of the vaccine's potential adverse effects and risk factors to increase the general population's awareness regarding the importance of emergent medical care.</AbstractText>
          <CopyrightInformation>© 2022 The Authors. Published by Elsevier Inc. on behalf of University of Washington.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sharbatdaran</LastName>
            <ForeName>Arman</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>St. George's University School of Medicine, St. George's, Grenada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Brooklyn Hospital Medical Center, 121 Dekalb Ave., Brooklyn, NY 11201, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chahal</LastName>
            <ForeName>Yasmeen</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>St. George's University School of Medicine, St. George's, Grenada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Brooklyn Hospital Medical Center, 121 Dekalb Ave., Brooklyn, NY 11201, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Molaei</LastName>
            <ForeName>Mirsadra</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutical Chemistry, Semmelweis University, Hőgyes E. str. 9, Budapest H-1085, Hungary.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bhavsar</LastName>
            <ForeName>Dishang</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>The Brooklyn Hospital Medical Center, 121 Dekalb Ave., Brooklyn, NY 11201, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Cardiovascular Medicine Fellow, Icahn School of Medicine at Mount Sinai/Brooklyn Hospital Center, 1 Gustave L. Levy Pl, New York, NY 10029, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Radiol Case Rep</MedlineTA>
        <NlmUniqueID>101467888</NlmUniqueID>
        <ISSNLinking>1930-0433</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">COVID-19</Keyword>
        <Keyword MajorTopicYN="N">Myocarditis</Keyword>
        <Keyword MajorTopicYN="N">Myopericarditis</Keyword>
        <Keyword MajorTopicYN="N">Pericardial effusion</Keyword>
        <Keyword MajorTopicYN="N">Pericarditis</Keyword>
        <Keyword MajorTopicYN="N">Vaccine</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>11</Day>
          <Hour>5</Hour>
          <Minute>29</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35401904</ArticleId>
        <ArticleId IdType="pmc">PMC8980502</ArticleId>
        <ArticleId IdType="doi">10.1016/j.radcr.2022.03.039</ArticleId>
        <ArticleId IdType="pii">S1930-0433(22)00213-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>FDA. COVID-19 Vaccines. 2021 01/03/2022 12/11/2021]; Available from: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines.</Citation>
        </Reference>
        <Reference>
          <Citation>Das B.B., et al.  Myocarditis and pericarditis following mRNA COVID-19 vaccination: what do we know so far? Children (Basel) 2021;8(7):2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8305058</ArticleId>
            <ArticleId IdType="pubmed">34356586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McLean K., Johnson T.J. Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: a case report. Acad Emerg Med. 2021;28(8):918–921.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8441784</ArticleId>
            <ArticleId IdType="pubmed">34133825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Imazio M., Cooper L.T. Management of myopericarditis. Expert Rev Cardiovasc Ther. 2013;11(2):193–201.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23405840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fazlollahi A., et al.  Cardiac complications following mRNA COVID-19 vaccines: a systematic review of case reports and case series. Rev Med Virol. 2021:1–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34921468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bozkurt B., Kamat I., Hotez P.J. Myocarditis With COVID-19 mRNA vaccines. Circulation. 2021;144(6):471–484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8340726</ArticleId>
            <ArticleId IdType="pubmed">34281357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Are you at risk for heart inflammation from COVID-19 or its vaccines? studies suggest seniors should not worry: myocarditis and pericarditis are rare and affect mostly teens and young adults. Heart advisor. 2022;25(1):1.</Citation>
        </Reference>
        <Reference>
          <Citation>Meisel S.R., et al.  Differentiation between myopericarditis and acute myocardial infarction on presentation in the emergency department using the admission C-reactive protein to troponin ratio. PloS One. 2021;16(4) e0248365-e0248365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8062049</ArticleId>
            <ArticleId IdType="pubmed">33886564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Friedrich M.G., Marcotte F. Cardiac magnetic resonance assessment of myocarditis. Circ Cardiovasc Imaging. 2013;6(5):833–839.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24046380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patone M., et al.  Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med. 2020;13(8):1854–1856.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8863574</ArticleId>
            <ArticleId IdType="pubmed">34907393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ambati S., et al.  Acute myopericarditis after COVID-19 vaccine in teenagers. Case Rep Cardiol. 2021;2021</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8476255</ArticleId>
            <ArticleId IdType="pubmed">34589238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fearon C., et al.  Takotsubo syndrome after receiving the COVID-19 vaccine. J Cardiol Cases. 2021;24(5):223–226.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8440167</ArticleId>
            <ArticleId IdType="pubmed">34539938</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim D., et al.  A case report for myopericarditis after BNT162b2 COVID-19 mRNA vaccination in a Korean young male. J Korean Med Sci. 2021;36(39)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8506415</ArticleId>
            <ArticleId IdType="pubmed">34636504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>CDC. Interim clinical considerations for use of COVID-19 vaccines currently approved or authorized in the United States. [website] 2022 2/11/2022 [cited 2022 2/11/2022]; Available from: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fvaccines%2Fcovid-19%2Finfo-by-product%2Fclinical-considerations.html.</Citation>
        </Reference>
        <Reference>
          <Citation>Snyder M.J.D.O., Bepko J.M.D., White M.D.O. Acute pericarditis: diagnosis and management. Am Fam Physician. 2014;89(7):553–560.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24695601</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
